Novel Pharmacological Treatments for Anorexia Nervosa
About this study
The Li-Transformative Hub for Research into Eating Disorders (Li-THRED) at Monash University is conducting a randomised controlled trial to investigate the effects of 3 repurposed medications on anorexia nervosa.
These medications include brexpiprazole, memantine, and zinc. It is hypothesised that these treatments will improve eating disorder symptoms as compared to placebo.
Research TeamProfessor Jayashri Kulkarni, Dr Eva Gregertsen, Dr Romi Goldschlager
InstitutionMonash University
Ethics Approval NumberHREC/101711/Alfred-2024
Funding SourcePhilanthropy
Project Start Date1 May 2024
Project End Date1 May 2027
ParticipantsIndividuals aged 16 and over living with anorexia nervosa (including in partial remission & atypical anorexia nervosa)
What is Involved5 visits to our research site in Melbourne over a 3 month duration + 1 additional visit 3 months after end of treatment.
Location607 St Kilda Road, Melbourne
Contact Details
THRED@monash.edu